By allowing ads to appear on this site, you support the local businesses who, in turn, support great journalism.
Ethical questions emerge over who gets Ebola drug
APTOPIX Spain Ebola Werm
In this photo provided by the Spanish Defense Ministry, aid workers and doctors transfer Miguel Pajares, a Spanish priest who was infected with the Ebola virus while working in Liberia, from a plane to an ambulance as he leaves the Torrejon de Ardoz military airbase, near Madrid, Spain, Thursday. - photo by Associated Press
MADRID — In a development that raises a host of ethical issues, Spain announced it had obtained a scarce U.S.-made experimental Ebola drug to treat a Spanish missionary priest infected with the killer virus. The Health Ministry statement came less than a week after the U.S. Centers for Disease Control and Prevention said there were virtually no doses available of the drug that was used to treat two Americans with the disease. The drug's maker, Mapp Pharmaceutical Inc. of San Diego, says "very little of the drug is currently available" and that is cooperating with government agencies to increase production as quickly as possible.
Sign up for the Herald's free e-newsletter